SonoThera Presents New Gene Therapy Data Showing 65% FVIII Levels at ASH Meeting
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 08 2025
0mins
Source: Businesswire
- New Data Presentation: SonoThera will present new research data at the ASH Annual Meeting on December 8, demonstrating that its UMD technology achieves FVIII protein levels of up to 65% of normal circulating levels in non-human primate models, offering new hope for Hemophilia A treatment.
- Technological Advantage: Utilizing its proprietary RIPPLE™ ultrasound-mediated delivery technology, SonoThera can safely and effectively deliver DNA expression vectors to the liver, overcoming limitations of current therapies related to variable expression and durability, thereby enhancing treatment efficacy.
- Clinical Potential: These positive research results not only showcase the potential of UMD technology in gene therapy but also indicate its ability to achieve high levels of functional FVIII expression, which could transform the treatment landscape for Hemophilia A and meet patient demands for more effective therapies.
- Future Outlook: SonoThera's technology aims to provide safe, well-tolerated, and cost-effective gene therapy solutions, which is expected to drive the development of its product pipeline and establish a significant position in the field of genetic medicine.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like SONO with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on SONO
Wall Street analysts forecast SONO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SONO is 19.67 USD with a low forecast of 17.00 USD and a high forecast of 21.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 14.340
Low
17.00
Averages
19.67
High
21.00
Current: 14.340
Low
17.00
Averages
19.67
High
21.00
About SONO
Sonos, Inc., and its wholly owned subsidiaries designs, develops, manufactures, and sells audio products and services. It offers customers a proprietary software platform, and the ability to stream content from a variety of sources over the customer’s wireless network or over Bluetooth. Its product lineup includes wireless, portable, and home theater speakers, headphones, components, and accessories. Its products are sold through third-party physical retailers, including custom installers of home audio systems, e-commerce retailers, and its Website sonos.com. Its products include Era 100, Era 300, Five, Roam 2, Move 2, Ray, Beam (Gen 2), Arc, Sub Mini, and Sub (Gen 3). Its proprietary software includes multi-room, multi-service experience, open platform for content partners, and smart audio tuning. Its products are distributed in more than 60 countries through retailer's physical stores and their websites, online retailers, custom installers who bundle its products with their services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sonos Inc. 2026 AI Monetization Outlook
- Financial Performance: Sonos Inc. reported Q4 2025 revenue of $288 million, a 13% year-over-year increase, although full-year revenue declined by 5% to $1.44 billion; the company successfully reduced its annual operating expenses by over $100 million, showcasing strong financial management.
- Profitability Improvement: The non-GAAP EPS rose by 31% to $0.64, reflecting the company's efforts in cost control and efficiency enhancement, despite the challenges posed by overall revenue decline.
- Strategic Transformation: CEO Thomas Conrad described 2026 as a new chapter, emphasizing the Sonos platform as a cohesive system for third-party and first-party AI experiences, aimed at enhancing market competitiveness and attracting more users.
- Market Challenges: Despite showing positive growth momentum, Sonos faces tariff pressures expected to impact margins by 300 basis points in Q1 and 400 basis points in Q2, with management proactively addressing these costs through strategic pricing and promotions.
Continue Reading
Peloton's Turnaround Journey: Market Prospects and Challenges
- Market Recovery: The S&P 500 has risen 71% over the past three years, boosting investor confidence and leading to a surge in popularity for exchange-traded funds (ETFs), reflecting a strong demand for growth-oriented investments.
- Peloton's Stock Potential: Despite Peloton's stock being down 96% from its all-time high, Wall Street analysts are optimistic about its price target over the next 12 to 18 months, with a consensus suggesting a 70% increase, and one analyst forecasting a staggering 236% gain.
- Strategic Transformation: Under CEO Peter Stern, Peloton is implementing a series of changes focused on enhancing member value, attracting new members, maintaining engagement, and achieving operational excellence, aiming to evolve into a growth enterprise.
- Financial Status and Challenges: While Peloton achieved $67 million in free cash flow and positive net income for two consecutive quarters in Q1 2026, its revenue still declined by 6% year-over-year, indicating ongoing challenges in its turnaround efforts.
Continue Reading